LET US HELP YOU EXPAND THE USE OF YOUR CANCER DRUG AND MAXIMIZE REVENUE AND PATENT LIFE

PBS-Bio repurposes oncology drugs to maximize revenue and patent life. Many approved and marketed oncology drugs are underperforming financially while valuable patent life is running out. The PBS-Bio team utilizes proprietary methods and world class experts to find new oncology indications and expand cancer markets. View Wall Street Journal Article

Discovering new drug indications realizes additional revenue and extends patent life